{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,5]],"date-time":"2026-07-05T04:30:26Z","timestamp":1783225826939,"version":"3.54.6"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,1,22]],"date-time":"2020-01-22T00:00:00Z","timestamp":1579651200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,1,22]],"date-time":"2020-01-22T00:00:00Z","timestamp":1579651200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Numerous evidences have shown that circular RNAs (circRNAs) play a key role in regulating the pathogenesis of cancer. However, the mechanism of circRNAs in urothelial carcinoma of bladder (UCB) remains largely unclear. In this study, we found circFAM114A2 was significantly downregulated both in UCB tissue specimens and cell lines, and the expression level was highly correlated with pathological TNM stage and grade. Functionally, overexpression of circFAM114A2 dramatically inhibited the migration, invasion and proliferation of UCB cells in vitro, and suppressed tumor growth in vivo. Mechanistically, we confirmed miR-762 was copiously pulled down by circFAM114A2 in 5637 and T24 cells. Fluorescence in situ hybridization (FISH) further indicated the cytoplasmic interactions between circFAM114A2 and miR-762. By using luciferase reporter assay, we found that miR-762 could directly target TP63. Subsequently, we found that circFAM114A2 might increase the expression of \u2206NP63 (main isoform of TP63 in UCB) by sponging miR-762. Taken together, our results demonstrated that circFAM114A2 might serve as a competing endogenous RNA (ceRNA) of miR-762 in regulating the expression of \u2206NP63, thus suppressed UCB progression through circFAM114A2\/miR-762\/\u2206NP63 axis.<\/jats:p>","DOI":"10.1038\/s41419-020-2226-5","type":"journal-article","created":{"date-parts":[[2020,1,22]],"date-time":"2020-01-22T13:03:05Z","timestamp":1579698185000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Circular RNA FAM114A2 suppresses progression of bladder cancer via regulating \u2206NP63 by sponging miR-762"],"prefix":"10.1038","volume":"11","author":[{"given":"Tianyao","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qun","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shangxun","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baofu","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjie","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minghui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanqing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongqian","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,1,22]]},"reference":[{"key":"2226_CR1","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.eururo.2016.06.010","volume":"71","author":"S Antoni","year":"2017","unstructured":"Antoni, S. et al. Bladder cancer incidence and mortality: a global overview and recent trends. Eur. Urol. 71, 96\u2013108 (2017).","journal-title":"Eur. Urol."},{"key":"2226_CR2","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3322\/caac.21338","volume":"66","author":"W Chen","year":"2016","unstructured":"Chen, W. et al. Cancer statistics in China, 2015. CA Cancer J. Clin. 66, 115\u2013132 (2016).","journal-title":"CA Cancer J. Clin."},{"key":"2226_CR3","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1016\/S0022-5347(05)65157-9","volume":"167","author":"MS Soloway","year":"2002","unstructured":"Soloway, M. S., Sofer, M. & Vaidya, A. Contemporary management of stage T1 transitional cell carcinoma of the bladder. J. Urol. 167, 1573\u20131583 (2002).","journal-title":"J. Urol."},{"key":"2226_CR4","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3322\/caac.21166","volume":"63","author":"R Siegel","year":"2013","unstructured":"Siegel, R., Naishadham, D. & Jemal, A. Cancer statistics, 2013. CA Cancer J. Clin. 63, 11\u201330 (2013).","journal-title":"CA Cancer J. Clin."},{"key":"2226_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11215","volume":"7","author":"QP Zheng","year":"2016","unstructured":"Zheng, Q. P. et al. Circular RNA profiling reveals an abundant circHIPK3 that regulates cell growth by sponging multiple miRNAs. Nat. Commun. 7, 11215 (2016).","journal-title":"Nat. Commun."},{"key":"2226_CR6","doi-asserted-by":"crossref","first-page":"47186","DOI":"10.18632\/oncotarget.9706","volume":"7","author":"MG Huang","year":"2016","unstructured":"Huang, M. G. et al. Comprehensive analysis of differentially expressed profiles of lncRNAs and circRNAs with associated co-expression and ceRNA networks in bladder carcinoma. Oncotarget 7, 47186\u201347200 (2016).","journal-title":"Oncotarget"},{"key":"2226_CR7","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/280339a0","volume":"280","author":"MT Hsu","year":"1979","unstructured":"Hsu, M. T. & Cocaprados, M. Electron-microscopic evidence for the circular form of RNA in the cytoplasm of eukaryotic cells. Nature 280, 339\u2013340 (1979).","journal-title":"Nature"},{"key":"2226_CR8","first-page":"18","volume":"9","author":"SP Barrett","year":"2015","unstructured":"Barrett, S. P., Wang, P. L. & Salzman, J. Circular RNA biogenesis can proceed through an exon-containing lariat precursor. Elife 9, 18 (2015).","journal-title":"Elife"},{"key":"2226_CR9","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1080\/15476286.2015.1020271","volume":"12","author":"LL Chen","year":"2015","unstructured":"Chen, L. L. & Yang, L. Regulation of circRNA biogenesis. RNA Biol. 12, 381\u2013388 (2015).","journal-title":"RNA Biol."},{"key":"2226_CR10","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1096\/fasebj.7.1.7678559","volume":"7","author":"C Cocquerelle","year":"1993","unstructured":"Cocquerelle, C., Mascrez, B., Hetuin, D. & Bailleul, B. Mis-splicing yields circular RNA molecules. FASEB J. 7, 155\u2013160 (1993).","journal-title":"FASEB J."},{"key":"2226_CR11","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/nature11928","volume":"495","author":"S Memczak","year":"2013","unstructured":"Memczak, S. et al. Circular RNAs are a large class of animal RNAs with regulatory potency. Nature 495, 333\u2013338 (2013).","journal-title":"Nature"},{"key":"2226_CR12","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1016\/j.molcel.2015.03.027","volume":"58","author":"A Rybak-Wolf","year":"2015","unstructured":"Rybak-Wolf, A. et al. Circular RNAs in the mammalian brain are highly abundant, conserved, and dynamically expressed. Mol. Cell 58, 870\u2013885 (2015).","journal-title":"Mol. Cell"},{"key":"2226_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1003777","volume":"9","author":"J Salzman","year":"2013","unstructured":"Salzman, J., Chen, R. E., Olsen, M. N., Wang, P. L. & Brown, P. O. Cell-type specific features of circular RNA expression. PLoS Genet. 9, e1003777 (2013).","journal-title":"PLoS Genet."},{"key":"2226_CR14","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1242\/dev.128074","volume":"143","author":"SP Barrett","year":"2016","unstructured":"Barrett, S. P. & Salzman, J. Circular RNAs: analysis, expression and potential functions. Development 143, 1838\u20131847 (2016).","journal-title":"Development"},{"key":"2226_CR15","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/nature11993","volume":"495","author":"TB Hansen","year":"2013","unstructured":"Hansen, T. B. et al. Natural RNA circles function as efficient microRNA sponges. Nature 495, 384\u2013388 (2013).","journal-title":"Nature"},{"key":"2226_CR16","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.cell.2009.01.002","volume":"136","author":"DP Bartel","year":"2009","unstructured":"Bartel, D. P. MicroRNAs: target recognition and regulatory functions. Cell 136, 215\u2013233 (2009).","journal-title":"Cell"},{"key":"2226_CR17","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/nrurol.2013.113","volume":"10","author":"H Yoshino","year":"2013","unstructured":"Yoshino, H. et al. Aberrant expression of microRNAs in bladder cancer. Nat. Rev. Urol. 10, 396\u2013404 (2013).","journal-title":"Nat. Rev. Urol."},{"key":"2226_CR18","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.eururo.2011.01.044","volume":"59","author":"JW Catto","year":"2011","unstructured":"Catto, J. W. et al. MicroRNA in prostate, bladder, and kidney cancer: a systematic review. Eur. Urol. 59, 671\u2013681 (2011).","journal-title":"Eur. Urol."},{"key":"2226_CR19","doi-asserted-by":"publisher","first-page":"3918","DOI":"10.1158\/1078-0432.CCR-16-2541","volume":"23","author":"W Weng","year":"2017","unstructured":"Weng, W. et al. Circular RNA ciRS-7-A promising prognostic biomarker and a potential therapeutic target in colorectal cancer. Clin. Cancer Res. 23, 3918\u20133928 (2017).","journal-title":"Clin. Cancer Res."},{"key":"2226_CR20","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1002\/hep.29270","volume":"66","author":"D Han","year":"2017","unstructured":"Han, D. et al. Circular RNA circMTO1 acts as the sponge of microRNA-9 to suppress hepatocellular carcinoma progression. Hepatology 66, 1151\u20131164 (2017).","journal-title":"Hepatology"},{"key":"2226_CR21","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s13046-017-0614-1","volume":"36","author":"R He","year":"2017","unstructured":"He, R. et al. circGFRA1 and GFRA1 act as ceRNAs in triple negative breast cancer by regulating miR-34a. J. Exp. Clin. Cancer Res. 36, 145 (2017).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"2226_CR22","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.15252\/embr.201643581","volume":"18","author":"YW Li","year":"2017","unstructured":"Li, Y. W. et al. CircHIPK3 sponges miR-558 to suppress heparanase expression in bladder cancer cells. EMBO Rep. 18, 1646\u20131659 (2017).","journal-title":"EMBO Rep."},{"key":"2226_CR23","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1111\/cpr.12223","volume":"48","author":"YP Li","year":"2015","unstructured":"Li, Y. P. et al. microRNA-762 promotes breast cancer cell proliferation and invasion by targeting IRF7 expression. Cell Prolif. 48, 643\u2013649 (2015).","journal-title":"Cell Prolif."},{"key":"2226_CR24","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.2147\/OTT.S127872","volume":"10","author":"R Hou.","year":"2017","unstructured":"Hou., R. et al. miR-762 can negatively regulate menin in ovarian cancer. Oncotargets Ther. 10, 2127\u20132137 (2017).","journal-title":"Oncotargets Ther."},{"key":"2226_CR25","doi-asserted-by":"crossref","first-page":"66455","DOI":"10.18632\/oncotarget.12186","volume":"7","author":"X Jin","year":"2016","unstructured":"Jin, X., Feng, C. Y., Xiang, Z., Chen, Y. P. & Li, Y. M. CircRNA expression pattern and circRNA-miRNA-mRNA network in the pathogenesis of nonalcoholic steatohepatitis. Oncotarget 7, 66455\u201366467 (2016).","journal-title":"Oncotarget"},{"key":"2226_CR26","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1038\/sj.bjc.6600764","volume":"88","author":"F Koga","year":"2003","unstructured":"Koga, F. et al. Impaired Delta Np63 expression associates with reduced beta-catenin and aggressive phenotypes of urothelial neoplasms. Br. J. Cancer 88, 740\u2013747 (2003).","journal-title":"Br. J. Cancer"},{"key":"2226_CR27","doi-asserted-by":"publisher","first-page":"4783","DOI":"10.1242\/dev.02621","volume":"133","author":"W Cheng","year":"2006","unstructured":"Cheng, W. et al. DeltaNp63 plays an anti-apoptotic role in ventral bladder development. Development 133, 4783\u20134792 (2006).","journal-title":"Development"},{"key":"2226_CR28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0030206","volume":"7","author":"W Choi","year":"2012","unstructured":"Choi, W. et al. p63 expression defines a lethal subset of muscle-invasive bladder cancers. PLoS ONE 7, e30206 (2012).","journal-title":"PLoS ONE"},{"key":"2226_CR29","doi-asserted-by":"publisher","first-page":"3275","DOI":"10.1074\/jbc.M112.408104","volume":"288","author":"MN Tran","year":"2013","unstructured":"Tran, M. N. et al. The p63 protein isoform DeltaNp63alpha inhibits epithelial-mesenchymal transition in human bladder cancer cells: role of MIR-205. J. Biol. Chem. 288, 3275\u20133288 (2013).","journal-title":"J. Biol. Chem."},{"key":"2226_CR30","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/S1097-2765(00)80275-0","volume":"2","author":"AN Yang","year":"1998","unstructured":"Yang, A. N. et al. p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol. Cell 2, 305\u2013316 (1998).","journal-title":"Mol. Cell"},{"key":"2226_CR31","first-page":"5501","volume":"9","author":"F Koga","year":"2003","unstructured":"Koga, F. et al. Impaired p63 expression associates with poor prognosis and uroplakin III expression in invasive urothelial carcinoma of the bladder. Clin. Cancer Res. 9, 5501\u20135507 (2003).","journal-title":"Clin. Cancer Res."},{"key":"2226_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-018-0889-7","volume":"17","author":"L Wang","year":"2018","unstructured":"Wang, L. et al. Circular RNA hsa_circ_0008305 (circPTK2) inhibits TGF-beta-induced epithelial-mesenchymal transition and metastasis by controlling TIF1gamma in non-small cell lung cancer. Mol. Cancer 17, 140 (2018).","journal-title":"Mol. Cancer"},{"key":"2226_CR33","doi-asserted-by":"publisher","first-page":"2339","DOI":"10.1158\/0008-5472.CAN-16-1883","volume":"77","author":"KY Hsiao","year":"2017","unstructured":"Hsiao, K. Y. et al. Noncoding effects of circular RNA CCDC66 promote colon cancer growth and metastasis. Cancer Res. 77, 2339\u20132350 (2017).","journal-title":"Cancer Res."},{"key":"2226_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-018-0914-x","volume":"17","author":"K Zeng","year":"2018","unstructured":"Zeng, K. et al. The pro-metastasis effect of circANKS1B in breast cancer. Mol. Cancer 17, 160 (2018).","journal-title":"Mol. Cancer"},{"key":"2226_CR35","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1159\/000495868","volume":"51","author":"Y An","year":"2018","unstructured":"An, Y. et al. circZMYM2 competed endogenously with miR-335-5p to regulate JMJD2C in pancreatic cancer. Cell Physiol. Biochem. 51, 2224\u20132236 (2018).","journal-title":"Cell Physiol. Biochem."},{"key":"2226_CR36","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1093\/bioinformatics\/btu257","volume":"30","author":"LF Thomas","year":"2014","unstructured":"Thomas, L. F. & Saetrom, P. Circular RNAs are depleted of polymorphisms at microRNA binding sites. Bioinformatics 30, 2243\u20132246 (2014).","journal-title":"Bioinformatics"},{"key":"2226_CR37","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.canlet.2017.06.027","volume":"403","author":"ZY Zhong","year":"2017","unstructured":"Zhong, Z. Y. et al. Circular RNA MYLK as a competing endogenous RNA promotes bladder cancer progression through modulating VEGFA\/VEGFR2 signaling pathway. Cancer Lett. 403, 305\u2013317 (2017).","journal-title":"Cancer Lett."},{"key":"2226_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-018-0892-z","volume":"17","author":"F Xie","year":"2018","unstructured":"Xie, F. et al. Circular RNA BCRC-3 suppresses bladder cancer proliferation through miR-182-5p\/p27 axis. Mol. Cancer 17, 144 (2018).","journal-title":"Mol. Cancer"},{"key":"2226_CR39","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1016\/S0002-9440(10)64396-9","volume":"161","author":"MJ Urist","year":"2002","unstructured":"Urist, M. J. et al. Loss of p63 expression is associated with tumor progression in bladder cancer. Am. J. Pathol. 161, 1199\u20131206 (2002).","journal-title":"Am. J. Pathol."}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-2226-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-2226-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-2226-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T14:37:16Z","timestamp":1670251036000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-020-2226-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,22]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,1]]}},"alternative-id":["2226"],"URL":"https:\/\/doi.org\/10.1038\/s41419-020-2226-5","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,22]]},"assertion":[{"value":"22 July 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"47"}}